These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18276136)

  • 1. Peptide backbone modifications on the C-terminal hexapeptide of neurotensin.
    Einsiedel J; Hübner H; Hervet M; Härterich S; Koschatzky S; Gmeiner P
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2013-8. PubMed ID: 18276136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy.
    Orwig KS; Lassetter MR; Hadden MK; Dix TA
    J Med Chem; 2009 Apr; 52(7):1803-13. PubMed ID: 19290594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
    Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insights into GPCR-peptide interactions: mutations in extracellular loop 1, ligand backbone methylations and molecular modeling of neurotensin receptor 1.
    Härterich S; Koschatzky S; Einsiedel J; Gmeiner P
    Bioorg Med Chem; 2008 Oct; 16(20):9359-68. PubMed ID: 18809332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of novel multimeric neurotensin(8-13) analogs.
    Hultsch C; Pawelke B; Bergmann R; Wuest F
    Bioorg Med Chem; 2006 Sep; 14(17):5913-20. PubMed ID: 16735124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues.
    Kokko KP; Hadden MK; Orwig KS; Mazella J; Dix TA
    J Med Chem; 2003 Sep; 46(19):4141-8. PubMed ID: 12954066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of neurotensin receptors in human corneal keratocytes.
    Bourcier T; Rondeau N; Paquet S; Forgez P; Lombet A; Pouzaud F; Rostène W; Borderie V; Laroche L
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1765-71. PubMed ID: 12036977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.
    Jia Y; Shi W; Zhou Z; Wagh NK; Fan W; Brusnahan SK; Garrison JC
    Nucl Med Biol; 2015 Nov; 42(11):816-23. PubMed ID: 26302836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and structure-activity relationships of C-terminal cyclic neurotensin fragment analogues.
    Sefler AM; He JX; Sawyer TK; Holub KE; Omecinsky DO; Reily MD; Thanabal V; Akunne HC; Cody WL
    J Med Chem; 1995 Jan; 38(2):249-57. PubMed ID: 7830267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin and neurotensin receptors: characteristic, structure-activity relationship and pain modulation--a review.
    Kleczkowska P; Lipkowski AW
    Eur J Pharmacol; 2013 Sep; 716(1-3):54-60. PubMed ID: 23500196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of lactam-bridged neurotensin analogues adjusting psi(Pro10) close to the experimentally derived bioactive conformation of NT(8-13).
    Bittermann H; Einsiedel J; Hübner H; Gmeiner P
    J Med Chem; 2004 Oct; 47(22):5587-90. PubMed ID: 15481995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR solution structure of neurotensin in membrane-mimetic environments: molecular basis for neurotensin receptor recognition.
    Coutant J; Curmi PA; Toma F; Monti JP
    Biochemistry; 2007 May; 46(19):5656-63. PubMed ID: 17441729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and functional characterization of a type-I neurotensin receptor (NTR) and a novel NTR from the bullfrog brain.
    Li JH; Sicard F; Salam MA; Baek M; LePrince J; Vaudry H; Kim K; Kwon HB; Seong JY
    J Mol Endocrinol; 2005 Jun; 34(3):793-807. PubMed ID: 15956348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor.
    Da Costa G; Bondon A; Coutant J; Curmi P; Monti JP
    J Biomol Struct Dyn; 2013 Dec; 31(12):1381-92. PubMed ID: 23140271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo behavioral effects of stable, receptor-selective neurotensin[8-13] analogues that cross the blood-brain barrier.
    Kokko KP; Hadden MK; Price KL; Orwig KS; See RE; Dix TA
    Neuropharmacology; 2005 Mar; 48(3):417-25. PubMed ID: 15721174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and human neurotensin receptor binding activities of neurotensin(8-13) analogues containing position 8 alpha-azido-N-alkylated derivatives of ornithine, lysine, and homolysine.
    Lundquist JT; Dix TA
    J Med Chem; 1999 Nov; 42(23):4914-8. PubMed ID: 10579853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the terminal homologation of physiologically active peptides as a means of increasing stability in human serum--neurotensin, opiorphin, B27-KK10 epitope, NPY.
    Seebach D; Lukaszuk A; Patora-Komisarska K; Podwysocka D; Gardiner J; Ebert MO; Reubi JC; Cescato R; Waser B; Gmeiner P; Hübner H; Rougeot C
    Chem Biodivers; 2011 May; 8(5):711-39. PubMed ID: 21560227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinities.
    Lundquist JT; Büllesbach EE; Dix TA
    Bioorg Med Chem Lett; 2000 Mar; 10(5):453-5. PubMed ID: 10743946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescein-labeled stable neurotensin derivatives.
    Maes V; Hultsch C; Kohl S; Bergmann R; Hanke T; Tourwé D
    J Pept Sci; 2006 Aug; 12(8):505-8. PubMed ID: 16671056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel form of neurotensin post-translationally modified by arginylation.
    Eriste E; Norberg A; Nepomuceno D; Kuei C; Kamme F; Tran DT; Strupat K; Jörnvall H; Liu C; Lovenberg TW; Sillard R
    J Biol Chem; 2005 Oct; 280(42):35089-97. PubMed ID: 16087676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.